Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

HIV Infection

Free Subscription 02.02.2026 20 AIDS 2 AIDS Res Hum Retroviruses 1 Am J Epidemiol 1 Am J Med 5 HIV Med 1 Int J Cancer 1 Int J Dermatol 2 J Acquir Immune Defic Syndr 1 J Clin Invest 2 J Infect Dis 1 J Virol 1 MMWR Morb Mortal Wkly Rep 2 Pediatr Infect Dis J 1 PLoS Comput Biol 3 PLoS One 2 PLoS Pathog 2 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. CANIGLIA EC, Zash R, Diseko M, Mabuta J, et al
   Target trials of pre-conception switch from Nevirapine- or Efavirenz-based ART to dolutegravir-based ART on adverse birth and maternal outcomes.
   AIDS. 2025 Aug 13. doi: 10.1097/QAD.0000000000004321.
   PubMed         Abstract available
   
   
2. BOROK MZ, Fiorillo S, Manyeruke F, Makoni T, et al
   Improved screening for pulmonary Kaposi sarcoma in a low-resource setting.
   AIDS. 2026 Jan 23. doi: 10.1097/QAD.0000000000004455.
   PubMed         Abstract available
   
   
3. VAN DYKE RB, Sawyer GW, Williams PL, Yu W, et al
   Longitudinal assessment of inflammatory biomarkers among youth living with perinatal HIV infection and HIV exposure.
   AIDS. 2026 Jan 23. doi: 10.1097/QAD.0000000000004454.
   PubMed         Abstract available
   
   
4. FRASER H, Stone J, Zienkiewicz A, Lim AG, et al
   Modelling the impact of underage and coerced entry into sex work on HIV transmission in Tijuana, Mexico.
   AIDS. 2026 Jan 23. doi: 10.1097/QAD.0000000000004452.
   PubMed         Abstract available
   
   
5. AVEDISSIAN SN, McCarthy C, Bosch RJ, Spudich S, et al
   A novel measure of antiretroviral activity in CSF and association with HIV persistence and cognitive function.
   AIDS. 2026 Jan 23. doi: 10.1097/QAD.0000000000004453.
   PubMed         Abstract available
   
   
6. MOYLE G, Assoumou L, De Castro N, Post FA, et al
   Durable efficacy of dolutegravir/rilpivirine switch in subjects with HIV RNA <50 copies/mL and history of K103N mutation.
   AIDS. 2026 Jan 23. doi: 10.1097/QAD.0000000000004451.
   PubMed         Abstract available
   
   
7. STEVENS O, Anderson RL, Sabin K, Garcia SA, et al
   HIV prevalence in transgender women and cisgender men who have sex with men in sub-Saharan Africa 2010-2022: a meta-analysis.
   AIDS. 2025 Nov 21. doi: 10.1097/QAD.0000000000004405.
   PubMed         Abstract available
   
   
8. FOSTER C
   Sexual and reproductive health issues facing young people with perinatal HIV infection.
   AIDS. 2025;39:1985-1995.
   PubMed         Abstract available
   
   
9. BISHOP MD, Xu L, Boyce CL, Drain PK, et al
   HIV-1 3? polypurine tract mutations and integrase inhibitor resistance.
   AIDS. 2025;39:1996-2013.
   PubMed         Abstract available
   
   
10. DIB H, Nowak R, Niyongabo B
    Retention challenges and cost-effective strategies for anal precancer screening in HIV-positive individuals: preventing progression to anal cancer.
    AIDS. 2025;39:2133-2135.
    PubMed        
    
    
11. GENER AR
    In lieu of an effective pan-viral curative treatment, does antiretroviral therapy help people clear non-HIV chronic infections?
    AIDS. 2025;39:2136-2137.
    PubMed        
    
    
12. CLARK J, Caceres C
    Centering the voices of transwomen in HIV prevention.
    AIDS. 2025;39:2138-2139.
    PubMed        
    
    
13. ROBERTS ST, Browne EN, Moore E, Mungo J, et al
    Longer-acting preexposure prophylaxis product and delivery preferences among transgender women in the United States: a discrete choice experiment.
    AIDS. 2025;39:2140-2142.
    PubMed         Abstract available
    
    
14. APOLLO T, Yeo YR, Mugurungi OM, Sithole N, et al
    Case study of PEPFAR funding cuts on HIV infections and deaths: reversing hard-won gains.
    AIDS. 2025;39:2143-2146.
    PubMed         Abstract available
    
    
15. GOHIL J, Mackie NE, Winston A
    The evolution of antiretroviral-associated drug-resistance mutations in an individual receiving dolutegravir/lamivudine.
    AIDS. 2025;39:2147-2149.
    PubMed        
    
    
16. AL-YASIRI L, Gill MJ, Krentz H, McMillan J, et al
    Impaired CD4+ T-cell and CD4+/CD8+ ratio recovery among people with HIV on antiretroviral therapy: prevalence and risk factors.
    AIDS. 2026 Jan 29. doi: 10.1097/QAD.0000000000004456.
    PubMed         Abstract available
    
    
17. ABRESCIA N
    Menopause and metabolic risk in women with HIV: beyond antiretroviral therapy.
    AIDS. 2026;40:392-393.
    PubMed        
    
    
18. DOS SANTOS AP, Oliveira VHF, Willig AL, Ruderman SA, et al
    Influence of the low-frequency extension filter on accelerometer-based activity measurements in people with HIV: a comparative analysis.
    AIDS. 2026;40:394-396.
    PubMed         Abstract available
    
    
19. MACIAS-GONZALEZ F, Vermandere H, Pineirua-Menendez A, Bautista-Arredondo S, et al
    Who is accessing PrEP in Mexico? Profiling users and identifying the unreached among high-risk MSM.
    AIDS. 2026;40:397-401.
    PubMed         Abstract available
    
    
20. SAH SS, Kumbhalwar A
    Letter to the editor regarding 'Post antiretroviral treatment dynamics of blood Epstein-Barr DNA among people with HIV'.
    AIDS. 2026;40:402-403.
    PubMed        
    
    

    
    AIDS Res Hum Retroviruses

21. YE L, Xu K, Luo W, Zhu M, et al
    Identification of a Novel HIV-1 Recombinant Form (CRF01_AE/07_BC) from an Elderly Individual in Hangzhou, Eastern China.
    AIDS Res Hum Retroviruses. 2026 Jan 27:8892229261416191.
    PubMed         Abstract available
    
    
22. WANG J, Zhang M, Qicheng J, Yanle Z, et al
    Mechanism of Action of San Ren Decoction in PLWH Treatment Determined Using Network Pharmacology Combined with Experimental Validation.
    AIDS Res Hum Retroviruses. 2026 Jan 27:8892229251411676.
    PubMed         Abstract available
    
    

    
    Am J Epidemiol

23. RENFRO ZT, Zulli A, Parsonnet J, Boehm A, et al
    Flush with data: harnessing emergency department wastewater as an innovative approach for surveillance of infectious diseases.
    Am J Epidemiol. 2026 Jan 29:kwag019. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Am J Med

24. GOZDAS HT
    Management of opportunistic pneumonia in an HIV/AIDS patient.
    Am J Med. 2026;139:e61.
    PubMed        
    
    

    
    HIV Med

25. LIMA LV, Pavinati G, Beraldi-Magalhaes F, Andrade-Goncalves RLP, et al
    Hierarchical analysis of unsuccessful tuberculosis treatment among people living with HIV in Brazil using nationwide surveillance data.
    HIV Med. 2026 Jan 28. doi: 10.1111/hiv.70200.
    PubMed         Abstract available
    
    
26. CAO T, Chen X, Chen H, Lu X, et al
    Preferences for long-acting antiretroviral therapy among people with HIV: A systematic review of discrete choice experiments.
    HIV Med. 2026 Jan 25. doi: 10.1111/hiv.70198.
    PubMed         Abstract available
    
    
27. DE VITO A, Marongiu A, Cano A, Puci M, et al
    Exploring the impact of Cabotegravir-Rilpivirine long-acting on weight gain, body composition and quality of life in adults living with HIV.
    HIV Med. 2026 Jan 28. doi: 10.1111/hiv.70202.
    PubMed         Abstract available
    
    
28. ELKHEIR N, Singh S, Barbini B, Campbell L, et al
    Screening for Trypanosoma cruzi infection (Chagas disease) in the Latin American population living with HIV in London.
    HIV Med. 2026 Jan 29. doi: 10.1111/hiv.70201.
    PubMed         Abstract available
    
    
29. TROYA J, Mican R, Galindo MJ, Bisbal O, et al
    Long-acting cabotegravir and rilpivirine in people with HIV and obesity: Real-world outcomes from the RELATIVITY cohort.
    HIV Med. 2026 Jan 25. doi: 10.1111/hiv.70196.
    PubMed         Abstract available
    
    

    
    Int J Cancer

30. MOHAMMED S, Galukande M, Naamala A, Parham G, et al
    Longitudinal changes in health-related quality of life after a breast cancer diagnosis in sub-Saharan Africa: Evidence from the prospective ABC-DO cohort.
    Int J Cancer. 2026 Jan 29. doi: 10.1002/ijc.70350.
    PubMed         Abstract available
    
    

    
    Int J Dermatol

31. GAUMOND SI, Mufarrej S, Angioli AM, Abdin R, et al
    Comorbidity Burden and Biologic Access in an Uninsured Psoriasis Population: A 20-Year Descriptive Study.
    Int J Dermatol. 2026 Jan 29. doi: 10.1111/ijd.70306.
    PubMed         Abstract available
    
    

    
    J Acquir Immune Defic Syndr

32. JAVANBAKHT M, Rosen AD, Moore E, Shoptaw S, et al
    Intersecting Vulnerabilities: The Role of Housing Instability and Methamphetamine Use on HIV Acquisition.
    J Acquir Immune Defic Syndr. 2026 Jan 26. doi: 10.1097/QAI.0000000000003836.
    PubMed         Abstract available
    
    
33. AYAFOR V, Downes A, Lewis-Chery S, Cabral HJ, et al
    Cancer Screening Rates, Disparities by Immigration Status and Predictors of Cancer Screening among Black Women with HIV.
    J Acquir Immune Defic Syndr. 2026 Jan 26. doi: 10.1097/QAI.0000000000003837.
    PubMed         Abstract available
    
    

    
    J Clin Invest

34. OMANGE WR, Varco-Merth BD, Fadeyi O, Marenco A, et al
    Boosting SIV-specific CD8+ T cell responses prior to ART interruption extends time to SIVmac239 rebound.
    J Clin Invest. 2026 Jan 29:e198294. doi: 10.1172/JCI198294.
    PubMed         Abstract available
    
    

    
    J Infect Dis

35. GANDHI RT, Bosch RJ, Chahroudi A
    New Insights from Perinatal HIV: A Way Forward for HIV Cure Research.
    J Infect Dis. 2026 Jan 30:jiag057. doi: 10.1093.
    PubMed        
    
    
36. DABEE S, Barnabas S, Versteeg B, Kullin B, et al
    High Prevalence and Genotypic Diversity of Persistent Chlamydia Trachomatis Infections Among South African Adolescent Girls and Young Women: A Tale of Two Cities.
    J Infect Dis. 2026 Jan 29:jiag023. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Virol

37. MCMAHON EK, Lochner JS, Lynch RM, Bosque A, et al
    Retinoids enhance NK effector function against HIV-infected CD4 T cells.
    J Virol. 2026 Jan 27:e0162025. doi: 10.1128/jvi.01620.
    PubMed         Abstract available
    
    

    
    MMWR Morb Mortal Wkly Rep

38. ZUN A, Meyer N, Flores D, Mohr T, et al
    Notes from the Field: Maximizing Tuberculosis Testing After a School-Based Exposure - Lake County, Illinois, 2025.
    MMWR Morb Mortal Wkly Rep. 2026;75:55-57.
    PubMed        
    
    

    
    Pediatr Infect Dis J

39. MASSA JD, Giganti MJ, Lindsey JC, Levin MJ, et al
    Body Mass Index and Vaccine-induced Immune Responses in Children Living With HIV.
    Pediatr Infect Dis J. 2026 Jan 28. doi: 10.1097/INF.0000000000005153.
    PubMed         Abstract available
    
    
40. GIFFORD A, Mashau R, Mpembe R, Khanyile D, et al
    Cryptococcal Antigenemia in South African Children Living With HIV.
    Pediatr Infect Dis J. 2026 Jan 28. doi: 10.1097/INF.0000000000005154.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

41. AGGARWAL M, Periwal V
    Forecasting drug resistant HIV protease evolution.
    PLoS Comput Biol. 2026;22:e1013913.
    PubMed         Abstract available
    
    

    
    PLoS One

42. FOTSO AS, Koukobo C, Silhol R, Kra AK, et al
    Knowledge, attitudes and practices relating to HIV self-testing following its introduction in the Bas-Sassandra region of Cote d'Ivoire: the case of the ATLAS project.
    PLoS One. 2026;21:e0314947.
    PubMed         Abstract available
    
    
43. BARON D, O'Shea NG, Lightfoot A, Kuo C, et al
    "My childhood affected my ability to be resilient in both good and bad ways": A mixed methods examination on the links between adverse childhood experiences, resilience, and transactional sex among young South African women.
    PLoS One. 2026;21:e0341216.
    PubMed         Abstract available
    
    
44. 
    Correction: A motif unique to the human dead-box protein DDX3 is important for nucleic acid binding, ATP hydrolysis, RNA/DNA unwinding and HIV-1 replication.
    PLoS One. 2026;21:e0341385.
    PubMed         Abstract available
    
    

    
    PLoS Pathog

45. HONG J, Deshpande A, Thakare Y, Simonovsky L, et al
    The host protein cyclophilin A restricts nuclear entry of HIV-1 mutants by reducing the elasticity of the viral capsid.
    PLoS Pathog. 2026;22:e1013910.
    PubMed         Abstract available
    
    
46. KIM Y, Anderson JL, Tumpach C, Solomon A, et al
    The effect of combining HIV latency reversal with inhibition of phosphoinositide-3 kinases or B-cell lymphoma-2 on the HIV reservoir.
    PLoS Pathog. 2026;22:e1013923.
    PubMed         Abstract available
    
    

    
    Vaccine

47. MANSFIELD ME, Okui L, Simon S, Hosangadi D, et al
    Understanding COVID-19 vaccination choices and development of a toolkit and training for Botswana, 2022-2023.
    Vaccine. 2026;75:128274.
    PubMed         Abstract available
    
    
48. PAXITZIS AN, Oyebanji OA, Olagunju OJ, Keresztesy D, et al
    Antibody responses to SARS-CoV-2 vaccine in nursing home residents support a Bi-annual update schedule.
    Vaccine. 2026;75:128240.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.